Kcm Investment Advisors LLC Amgen Inc Transaction History

Kcm Investment Advisors LLC

$2.68 Billion
Q1 2024

A detailed history of Kcm Investment Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Kcm Investment Advisors LLC holds 91,125 shares of AMGN stock, worth $28.5 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

91,125

Previous 90,782 0.38%

Holding current value

$28.5 Million

Previous $26.1 Million 0.91%

% of portfolio

0.97%

Previous 1.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$268.87 - $324.56 $92,222 - $111,324	343 Added 0.38%	91,125 $25.9 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $36,565 - $41,249	143 Added 0.16%	90,782 $26.1 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $72,591 - $90,124	-332 Reduced 0.36%	90,639 $24.4 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $122,990 - $145,434	-574 Reduced 0.63%	90,971 $20.2 Million
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $43,577 - $53,113	-193 Reduced 0.21%	91,545 $22.1 Million

Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $110,392 - $140,266	482 Added 0.53%	91,738 $24.1 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $490,894 - $553,639	-2,187 Reduced 2.34%	91,256 $20.6 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $314,227 - $349,679	-1,362 Reduced 1.44%	93,443 $22.7 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $143,183 - $158,398	653 Added 0.69%	94,805 $22.9 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $4.12 Million - $4.71 Million	-20,692 Reduced 18.02%	94,152 $21.2 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $983,871 - $1.15 Million	4,635 Added 4.21%	114,844 $24.4 Million
Q2 2021 Oct 21, 2021	SELL	$233.58 - $259.14 $21 Million - $23.3 Million	-89,724 Reduced 44.88%	110,209 $26.9 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $22.3 Million - $24.7 Million	95,407 Added 91.28%	199,933 $28.1 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $2.69 Million - $3.13 Million	12,121 Added 13.12%	104,526 $26 Million
Q4 2020 Feb 19, 2021	BUY	$216.38 - $257.67 $1.5 Million - $1.79 Million	6,934 Added 8.11%	92,405 $21.2 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $2.34 Million - $2.6 Million	9,960 Added 13.19%	85,471 $21.7 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $1.04 Million - $1.28 Million	5,281 Added 7.52%	75,511 $17.8 Million
Q1 2020 Apr 27, 2020	SELL	$182.24 - $241.7 $9,112 - $12,085	-50 Reduced 0.07%	70,230 $14.2 Million
Q4 2019 Feb 18, 2020	BUY	$189.21 - $243.2 $1.12 Million - $1.43 Million	5,899 Added 9.16%	70,280 $16.9 Million
Q3 2019 Nov 15, 2019	BUY	$174.11 - $208.62 $1.18 Million - $1.42 Million	6,783 Added 11.78%	64,381 $12.5 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $1.16 Million - $1.36 Million	6,943 Added 13.71%	57,598 $10.6 Million
Q1 2019 May 16, 2019	BUY	$180.87 - $203.88 $979,772 - $1.1 Million	5,417 Added 11.97%	50,655 $9.62 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $1.33 Million - $1.55 Million	7,451 Added 19.72%	45,238 $8.81 Million
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $4.33 Million - $4.88 Million	23,342 Added 161.59%	37,787 $0
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $86,844 - $97,544	523 Added 3.76%	14,445 $2.67 Million
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $375,287 - $438,570	-2,215 Reduced 13.73%	13,922 $2.37 Million
Q4 2017 Feb 22, 2018	BUY	$168.79 - $188.59 $29,707 - $33,191	176 Added 1.1%	16,137 $2.81 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $2.67 Million - $3.05 Million	15,961	15,961 $2.98 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kcm Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kcm Investment Advisors LLC with notifications on news.

Account

Kcm Investment Advisors LLC Amgen Inc Transaction History